["{\n\"step_by_step_thinking\": \"The question is about a pregnant, diabetic female shifted to insulin. The first thing to consider is the movement from oral hypoglycemics to insulin. This suggests that the patient's condition may be more severe and requiring closer monitoring and management. Pregnancy can increase insulin requirements, but sulphonylureas are not suitable for this stage of life due to concerns about fetal growth. Tolbutamide is a sulphonylurea, so it cannot be used during pregnancy. PIH (Pregnancy-Induced Hypertension) is not directly related to the topic of insulin therapy in pregnancy.\n\nFrom the provided documents, we can see that Syndrome X discusses insulin resistance and its potential link to hypertension. There is also a mention of Folk healing causing severe diabetic coma, highlighting the importance of proper treatment and management. Don't choke on this: a swallowing assessment provides information about dysphagia, but it does not directly relate to the topic at hand. Why control diabetes? explains the difficulties in achieving optimal glucose levels, while [Effect of prolonged nicotinic acid load on the tolbutamide test] discusses the effect of nicotinic acid on carbohydrate metabolism.\n\nBased on this analysis, option C: Tolbutamide crosses placenta is incorrect because sulphonylureas do not cross the placenta and are not suitable for use during pregnancy.\",\n\"answer_choice\": \"C\"\n}"]